Related Experiment Video
Updated: Mar 1, 2026
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era
Sammy Elmariah1, Dabit Arzamendi1, Igor F Palacios1
1Interventional Cardiology, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, GBR 800, Boston, MA 02114, USA; Structural Heart Disease, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, GBR 800, Boston, MA 02114, USA.
Abstract:
Initial enthusiasm for balloon aortic valvuloplasty (BAV) as an alternative to surgical aortic valve replacement waned because of the perceived failure of the procedure to alter the natural history of calcific severe aortic valve stenosis (AS) and significant initial procedural morbidity. Despite technical and procedural advances, BAV has been reserved as a palliative procedure for patients who cannot undergo valve replacement or as a bridge to surgery in hemodynamically unstable patients. This article reviews the indications, technical aspects, and outcomes of BAV for calcific AS and discusses the current role of BAV in the era of transcatheter aortic valve replacement.
